FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Can Vet J / Hemagglutinin inhibition antibody responses to commercial eq...
The Canadian veterinary journal = La revue veterinaire canadienne2021; 62(3); 266-272;

Hemagglutinin inhibition antibody responses to commercial equine influenza vaccines in vaccinated horses.

Abstract: The use of a hemagglutination inhibition (HI) assay to assess humoral immune response to equine influenza virus (EIV) vaccines from various manufacturers administered to previously immunized adult horses was investigated. Subjects were allocated into one of 3 groups and vaccinated with various commercially available vaccines. Groups were subdivided into subjects that received 1 dose of a particular vaccine and those that received a second dose, 30 d later. Serum was collected at various times to assess antibody responses to contemporary EIV Florida sub-lineage strains. Statistical significance was set at < 0.05 and all groups had a significant increase in antibody titers pre- and post-administration of the first dose. In contrast, there was no significant difference between day 30 titers and titers at subsequent time points, regardless of protocol. We concluded that administration of various commercial influenza vaccines containing a different sub-lineage clade stimulated equivalent HI antibody titers after 1 booster vaccination. On a étudié l’utilisation d’un test d’inhibition de l’hémagglutination (HI) pour évaluer la réponse immunitaire humorale aux vaccins contre le virus de la grippe équine (EIV) de différents fabricants administrés à des chevaux adultes préalablement immunisés. Les sujets ont été divisés en trois groupes et vaccinés avec différents vaccins disponibles dans le commerce. Les groupes ont été subdivisés en sujets qui ont reçu une dose d’un vaccin particulier et ceux qui ont reçu une deuxième dose 30 jours plus tard. Du sérum a été prélevé à divers moments pour évaluer les réponses en anticorps aux souches contemporaines de la sous-lignée EIV Floride. La signification statistique a été fixée à < 0,05 et tous les groupes ont montré une différence significative entre les titres d’anticorps mesurés avant et après l’administration de la première dose. En revanche, il n’y avait pas de différence significative entre les titres au jour 30 et les titres à des moments ultérieurs, quel que soit le protocole. Les résultats ont montré que l’administration d’un vaccin antigrippal commercial différent contenant un clade de sous-lignée différent stimule des titres d’anticorps HI équivalents après une vaccination de rappel.(Traduit par D Serge Messier).
Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.
Get Full Text
Publication Date: 2021-03-12 PubMed ID: 33692582PubMed Central: PMC7877680
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study examines how the use of a hemagglutination inhibition (HI) assay can test the humoral immune response in horses previously immunized and given various commercially available equine influenza virus (EIV) vaccines. The investigation shows a significant increase in antibody titers after the first vaccine dose but no significant difference with further doses.

Research design

  • The researchers divided the subjects, which were previously immunized adult horses, into three groups, each getting different commercially available EIV vaccines.
  • Each group was further divided into two subgroups. One subgroup received one dose of the assigned vaccine, and the other received a second dose 30 days later.
  • The researchers collected serum from the horses at different times to assess the antibody responses to contemporary EIV Florida sub-lineage strains.

Data analysis

  • The researchers set the bar for statistical significance at < 0.05.
  • All groups displayed a significant increase in antibody titers measured before and after administrating the first dose.
  • However, there were no statistically significant differences between the antibody titers on day 30 and the titers at subsequent time points, regardless of the actual protocol followed.

Conclusions

  • From the data analyzed, the researchers concluded that the administration of various commercial influenza vaccines containing a different sub-lineage clade (a group of viruses with a common descent) stimulates similar HI antibody titers after a single booster vaccination.

Implications

  • This research suggests that one dose of a boosted vaccine can effectively increase horses’ antibody response against EIV, irrespective of the vaccine’s manufacturer.
  • However, the following doses don’t seem to lend any additional significant increase in the antibody titers.
  • This study could guide veterinarians and horse owners when choosing vaccines and deciding on vaccination plans, possibly contributing to more efficient equine influenza management and prevention.

Cite This Article

APA
Karam B, Wilson WD, Chambers TM, Reedy S, Pusterla N. (2021). Hemagglutinin inhibition antibody responses to commercial equine influenza vaccines in vaccinated horses. Can Vet J, 62(3), 266-272.

Publication

The Canadian veterinary journal = La revue veterinaire canadienne
ISSN: 0008-5286
NlmUniqueID: 0004653
Country: Canada
Language: English
Volume: 62
Issue: 3
Pages: 266-272

Researcher Affiliations

Karam, Bruno
  • William R. Pritchard Veterinary Medical Teaching Hospital (Karam), Department of Medicine and Epidemiology (Wilson, Pusterla), School of Veterinary Medicine, University of California, Davis, California, USA; Department of Veterinary Science, Maxwell H. Gluck Equine Research Center, University of Kentucky, Lexington, Kentucky, USA (Chambers, Reedy).
Wilson, William D
  • William R. Pritchard Veterinary Medical Teaching Hospital (Karam), Department of Medicine and Epidemiology (Wilson, Pusterla), School of Veterinary Medicine, University of California, Davis, California, USA; Department of Veterinary Science, Maxwell H. Gluck Equine Research Center, University of Kentucky, Lexington, Kentucky, USA (Chambers, Reedy).
Chambers, Thomas M
  • William R. Pritchard Veterinary Medical Teaching Hospital (Karam), Department of Medicine and Epidemiology (Wilson, Pusterla), School of Veterinary Medicine, University of California, Davis, California, USA; Department of Veterinary Science, Maxwell H. Gluck Equine Research Center, University of Kentucky, Lexington, Kentucky, USA (Chambers, Reedy).
Reedy, Stephanie
  • William R. Pritchard Veterinary Medical Teaching Hospital (Karam), Department of Medicine and Epidemiology (Wilson, Pusterla), School of Veterinary Medicine, University of California, Davis, California, USA; Department of Veterinary Science, Maxwell H. Gluck Equine Research Center, University of Kentucky, Lexington, Kentucky, USA (Chambers, Reedy).
Pusterla, Nicola
  • William R. Pritchard Veterinary Medical Teaching Hospital (Karam), Department of Medicine and Epidemiology (Wilson, Pusterla), School of Veterinary Medicine, University of California, Davis, California, USA; Department of Veterinary Science, Maxwell H. Gluck Equine Research Center, University of Kentucky, Lexington, Kentucky, USA (Chambers, Reedy).

MeSH Terms

  • Animals
  • Antibodies, Viral
  • Antibody Formation
  • Hemagglutinins
  • Horse Diseases / prevention & control
  • Horses
  • Influenza Vaccines
  • Orthomyxoviridae Infections / prevention & control
  • Orthomyxoviridae Infections / veterinary
  • Vaccination / veterinary

References

This article includes 25 references
  1. Landolt GA, Townsend HGG, Lunn DP. Equine influenza infection. In: Sellon DC, Long MT, editors. Equine Infectious Disease. 2nd ed. Philadelphia, Pennsylvania: Saunders Elsevier; 2014. pp. 141–151.
  2. Paillot R. A Systematic Review of Recent Advances in Equine Influenza Vaccination.. Vaccines (Basel) 2014 Nov 14;2(4):797-831.
    pmc: PMC4494246pubmed: 26344892doi: 10.3390/vaccines2040797google scholar: lookup
  3. OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 8th ed. World Organisation for Animal Health (OIE); Paris, France: 2019. pp. 1–19.
  4. Alves Beuttemmüller E, Woodward A, Rash A, Dos Santos Ferraz LE, Fernandes Alfieri A, Alfieri AA, Elton D. Characterisation of the epidemic strain of H3N8 equine influenza virus responsible for outbreaks in South America in 2012.. Virol J 2016 Mar 19;13:45.
    pmc: PMC4799594pubmed: 26993620doi: 10.1186/s12985-016-0503-9google scholar: lookup
  5. Brister H, Barnum SM, Reedy S, Chambers TM, Pusterla N. Validation of two multiplex real-time PCR assays based on single nucleotide polymorphisms of the HA1 gene of equine influenza A virus in order to differentiate between clade 1 and clade 2 Florida sublineage isolates.. J Vet Diagn Invest 2019 Jan;31(1):137-141.
    pmc: PMC6505758pubmed: 30803412doi: 10.1177/1040638718822693google scholar: lookup
  6. Landolt GA. Equine influenza virus.. Vet Clin North Am Equine Pract 2014 Dec;30(3):507-22.
    pubmed: 25282321doi: 10.1016/j.cveq.2014.08.003google scholar: lookup
  7. . Equine Influenza. American Association of Equine Practitioners .
  8. Chambers TM, Reedy SE. Equine Influenza Serological Methods.. Methods Mol Biol 2020;2123:401-412.
    pubmed: 32170706doi: 10.1007/978-1-0716-0346-8_31google scholar: lookup
  9. Cullinane A, Weld J, Osborne M, Nelly M, Mcbride C, Walsh C. Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings.. Vet J 2001 Mar;161(2):174-85.
    pubmed: 11243687doi: 10.1053/tvjl.2000.0546google scholar: lookup
  10. Gildea S, Arkins S, Walsh C, Cullinane A. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.. Vaccine 2011 Nov 15;29(49):9214-23.
    pubmed: 21983355doi: 10.1016/j.vaccine.2011.09.101google scholar: lookup
  11. Ryan M, Gildea S, Walsh C, Cullinane A. The impact of different equine influenza vaccine products and other factors on equine influenza antibody levels in Thoroughbred racehorses.. Equine Vet J 2015 Nov;47(6):662-6.
    pubmed: 25238593doi: 10.1111/evj.12353google scholar: lookup
  12. Cullinane A, Gildea S, Weldon E. Comparison of primary vaccination regimes for equine influenza: working towards an evidence-based regime.. Equine Vet J 2014 Nov;46(6):669-73.
    pubmed: 24237177doi: 10.1111/evj.12214google scholar: lookup
  13. Cowled B, Ward MP, Hamilton S, Garner G. The equine influenza epidemic in Australia: spatial and temporal descriptive analyses of a large propagating epidemic.. Prev Vet Med 2009 Nov 1;92(1-2):60-70.
    pubmed: 19748691doi: 10.1016/j.prevetmed.2009.08.006google scholar: lookup
  14. Ito M, Nagai M, Hayakawa Y, Komae H, Murakami N, Yotsuya S, Asakura S, Sakoda Y, Kida H. Genetic Analyses of an H3N8 Influenza Virus Isolate, Causative Strain of the Outbreak of Equine Influenza at the Kanazawa Racecourse in Japan in 2007.. J Vet Med Sci 2008 Sep;70(9):899-906.
    pubmed: 18840963doi: 10.1292/jvms.70.899google scholar: lookup
  15. Kinsley R, Scott SD, Daly JM. Controlling equine influenza: Traditional to next generation serological assays.. Vet Microbiol 2016 May 1;187:15-20.
    pubmed: 27066704doi: 10.1016/j.vetmic.2016.03.006google scholar: lookup
  16. Nemoto M, Yamanaka T, Bannai H, Tsujimura K, Kokado H. Complete Genomic Sequences of H3N8 Equine Influenza Virus Strains Used as Vaccine Strains in Japan.. Genome Announc 2018 Mar 22;6(12).
    pmc: PMC5864938pubmed: 29567739doi: 10.1128/genomea.00172-18google scholar: lookup
  17. Yamanaka T, Nemoto M, Bannai H, Tsujimura K, Matsumura T, Kokado H, Gildea S, Cullinane A. Neutralization antibody response to booster/priming immunization with new equine influenza vaccine in Japan.. J Vet Med Sci 2018 Mar 2;80(2):382-386.
    pmc: PMC5836781pubmed: 29237998doi: 10.1292/jvms.17-0538google scholar: lookup
  18. Barbic L, Madic J, Turk N, Daly J. Vaccine failure caused an outbreak of equine influenza in Croatia.. Vet Microbiol 2009 Jan 1;133(1-2):164-71.
    pubmed: 18632226doi: 10.1016/j.vetmic.2008.06.009google scholar: lookup
  19. Rash A, Morton R, Woodward A, Maes O, McCauley J, Bryant N, Elton D. Evolution and Divergence of H3N8 Equine Influenza Viruses Circulating in the United Kingdom from 2013 to 2015.. Pathogens 2017 Feb 8;6(1).
    pmc: PMC5371894pubmed: 28208721doi: 10.3390/pathogens6010006google scholar: lookup
  20. Horspool LJ, King A. Equine influenza vaccines in Europe: a view from the animal health industry.. Equine Vet J 2013 Nov;45(6):774-5.
    pubmed: 24117938doi: 10.1111/evj.12171google scholar: lookup
  21. Elton D, Cullinane A. Equine influenza: antigenic drift and implications for vaccines.. Equine Vet J 2013 Nov;45(6):768-9.
    pubmed: 24117935doi: 10.1111/evj.12148google scholar: lookup
  22. Morley PS, Hanson LK, Bogdan JR, Townsend HG, Appleton JA, Haines DM. The relationship between single radial hemolysis, hemagglutination inhibition, and virus neutralization assays used to detect antibodies specific for equine influenza viruses.. Vet Microbiol 1995 Jun;45(1):81-92.
    pubmed: 7653031doi: 10.1016/0378-1135(94)00105-6google scholar: lookup
  23. Paillot R, Garrett D, Lopez-Alvarez MR, Birand I, Montesso F, Horspool L. The Immunity Gap Challenge: Protection against a Recent Florida Clade 2 Equine Influenza Strain.. Vaccines (Basel) 2018 Jul 2;6(3).
    pmc: PMC6161116pubmed: 30004410doi: 10.3390/vaccines6030038google scholar: lookup
  24. Cullinane A, Gahan J, Walsh C, Nemoto M, Entenfellner J, Olguin-Perglione C, Garvey M, Huang Fu TQ, Venner M, Yamanaka T, Barrandeguy M, Fernandez CJ. Evaluation of Current Equine Influenza Vaccination Protocols Prior to Shipment, Guided by OIE Standards.. Vaccines (Basel) 2020 Feb 29;8(1).
    pmc: PMC7157717pubmed: 32121419doi: 10.3390/vaccines8010107google scholar: lookup
  25. Tabynov K, Kydyrbayev Zh, Ryskeldinova Sh, Assanzhanova N, Sansyzbay A. Duration of the protective immune response after prime and booster vaccination of yearlings with a live modified cold-adapted viral vaccine against equine influenza.. Vaccine 2014 May 23;32(25):2965-71.
    pubmed: 24726250doi: 10.1016/j.vaccine.2014.03.095google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.